Seal of Excellence SME Instrument of EU Horizontal 2020 Program in 2018-2019

calendar icon

SunRegen has received funding from the European Union’s SME Instrument Phase 1 program under grant agreement No 827153.

Seal of Excellence SME Instrument of EU Horizontal 2020 Program in 2018-2019

Supported By:

SunRegen Healthcare AG is a biopharmaceutical company to develop drugs for the unmet medical needs of Neurodegenerative diseases and ophthalmic diseases.

Quick Links

Contacts Info

+41 76 461 6688

SunRegen Healthcare AG
Business Parc Reinach
Christoph Merian-Ring 11, 4153 Reinach Switzerland

[email protected]